|
CN105287561A
|
|
Medicinal composition for treating ulcerative colitis
|
|
CN105030842A
|
|
Application of bacteroides intestinalis DSM 17393 strain
|
|
CN105106245A
|
|
Application of Akkermansia muciniphila BAA-835 bacterial strain
|
|
CN105030841A
|
|
Application of Akkermansia muciniphila BAA-835 strain
|
|
CN105136781A
|
|
Applications of adipokine GREM2 in preparation of obesity treatment drugs
|
|
CN105136780A
|
|
Applications of secretion factor GREM2 in preparation of obesity screening reagent
|
|
CN105031619A
|
|
Application of excreted factor GREM2 to 2-type diabetic therapy drug preparation
|
|
CN105106243A
|
|
Application of Bacteroides thetaiotaomicron VPI-5482 in preparation of pharmaceuticals for treating or preventing obesity
|
|
CN104933751A
|
|
Angiocarpy coronary artery enhanced volume rendering method and system based on local histograms
|
|
CN105030749A
|
|
Application of sodium valproate in preparation of medicaments for preventing and treating graft-versus-host disease
|
|
CN104984365A
|
|
Application of Pprc1 gene in preparation of disease screening reagent
|
|
CN104957094A
|
|
Method for building multi-tissue beta-catenin knockout mouse model
|
|
CN105018562A
|
|
Oxidative stress test method of MC3T3-E1 osteoblast
|
|
CN105145470A
|
|
Construction method for mature adipose tissue beta-catenin knocked-out mouse model
|
|
CN104940961A
|
|
Intragastric pH detection pellet and application thereof
|
|
CN104940823A
|
|
Qinhuang mixture for treating B cell lymphoma and application of qinhuang mixture
|
|
CN104739831A
|
|
Application of berberine to preparing drug for treating B cell lymphoma
|
|
CN104826141A
|
|
Application of nano silver in preparation of medicine for increasing retention of radioiodine in tumor cells
|
|
CN104906088A
|
|
Application of berberine in preparation of medicine for treating T cell lymjphoma
|
|
CN104922672A
|
|
Medicine composition for treating pituitary adenoma, application of medicine composition, medicine box and packaging piece
|
